Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class ...
The global induced pluripotent stem cells market size is calculated at USD 2.13 billion in 2025 and is expected to reach ...
Conventional human pluripotent stem cells at the primed pluripotent state are capable of generating all the embryonic lineages. However, their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback